Literature DB >> 18804960

Novel rating scales for schizophrenia - Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz).

Takefumi Suzuki1, Hiroyuki Uchida, Kensuke Nomura, Hiroyoshi Takeuchi, Shinichiro Nakajima, Akira Tanabe, Gohei Yagi, Koichiro Watanabe, Haruo Kashima.   

Abstract

OBJECTIVE: Many rating scales have been in use to evaluate various symptomatic domains, and eventually there are too many scales to be selected and widely utilized in busy real-world settings. Relevant, quick, and user-friendly assessment scales are needed to facilitate measurement-based treatment of schizophrenia.
METHODS: The authors created unique convenient assessment scales: Targeted Inventory on Problems in Schizophrenia (TIP-Sz), and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz). The TIP-Sz consists of 10 items (behavioral dyscontrol/disorganization, hostility/agitation/violence, indifference/affective withdrawal/motor retardation, symptoms on mood/anxiety/obsession/compulsion, insight/reality testing, social competence/independence, adherence to treatment, therapeutic alliance/comfort of therapists on the situation, overall prognostic impression, and subjective well-being/satisfaction with therapy). They are all common and frequently problematic, and each item is rated from 0-10. The FACT-Sz evaluates psychosocial functioning of patients with a score of 0-100, and is judged entirely on an objective basis. Their correlations with the frequently utilized Positive and Negative Syndrome Scale (PANSS), Global Assessment of Functioning (GAF), and Clinical Global Impression-Severity subscale were determined.
RESULTS: Data on 36 patients, assessed separately by four experienced psychiatrists, were analyzed. Under an excellent interrater reliability among raters (Intraclass correlation coefficients: 0.822-0.966), correlations among the scales were very high (Spearman's rho: 0.825-0.909), and other indicators of the scale were generally good. Specifically, the TIP-Sz and FACT-Sz could be rated at 1/3-1/4 of time to complete the PANSS and GAF.
CONCLUSION: The TIP-Sz and FACT-Sz proved to be reliable and valid, which would be of value in daily clinical practice as a minimum standardized assessment set.

Entities:  

Mesh:

Year:  2008        PMID: 18804960     DOI: 10.1016/j.schres.2008.08.013

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

1.  Subtyping Schizophrenia by Social Functioning - a Pragmatic Proposal for Clinics and Research.

Authors:  Takefumi Suzuki
Journal:  Psychiatr Q       Date:  2018-09

Review 2.  Which rating scales are regarded as 'the standard' in clinical trials for schizophrenia? A critical review.

Authors:  Takefumi Suzuki
Journal:  Psychopharmacol Bull       Date:  2011

Review 3.  Yoga versus standard care for schizophrenia.

Authors:  Julie Broderick; Abigail Knowles; Jonathan Chadwick; Davy Vancampfort
Journal:  Cochrane Database Syst Rev       Date:  2015-10-21

4.  Is there a linear relationship between the Brief Psychiatric Rating Scale and the Clinical Global Impression-Schizophrenia scale? A retrospective analysis.

Authors:  Jitsuki Sawamura; Shigeru Morishita; Jun Ishigooka
Journal:  BMC Psychiatry       Date:  2010-12-07       Impact factor: 3.630

5.  Clinical Characteristics of Patients with Schizophrenia Maintained without Antipsychotics: A Cross-sectional Survey of a Case Series.

Authors:  Hideaki Tani; Masayuki Tomita; Takefumi Suzuki; Masaru Mimura; Hiroyuki Uchida
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-11-30       Impact factor: 2.582

6.  Factor structure of the targeted inventory on problems in schizophrenia.

Authors:  Shoji Tanaka; Takanori Nagase; Takefumi Suzuki; Kensuke Nomura; Hiroyoshi Takeuchi; Shinichiro Nakajima; Hiroyuki Uchida; Gohei Yagi; Koichiro Watanabe; Masaru Mimura
Journal:  Clin Psychopharmacol Neurosci       Date:  2013-04-24       Impact factor: 2.582

7.  An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia.

Authors:  Jinichi Hirano; Koichiro Watanabe; Takefumi Suzuki; Hiroyuki Uchida; Ryosuke Den; Taishiro Kishimoto; Takashi Nagasawa; Yusuke Tomita; Koichiro Hara; Hiromi Ochi; Yoshimi Kobayashi; Mutsuko Ishii; Akane Fujita; Yoshihiko Kanai; Megumi Goto; Hiromi Hayashi; Kanako Inamura; Fumiko Ooshima; Mariko Sumida; Tomoko Ozawa; Kayoko Sekigawa; Maki Nagaoka; Kae Yoshimura; Mika Konishi; Ataru Inagaki; Takuya Saito; Nobutaka Motohashi; Masaru Mimura; Yoshiro Okubo; Motoichiro Kato
Journal:  Neuropsychiatr Dis Treat       Date:  2013-10-11       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.